Current Ratio of Sigyn Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Sigyn Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Sigyn Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 0.92%, a 78% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Sigyn Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 0.92% -3.2% -78% 30 Sep 2025
Q2 2025 1.8% -1.8% -49% 30 Jun 2025
Q1 2025 2.8% -0.88% -24% 31 Mar 2025
Q4 2024 3.4% -2.8% -45% 31 Dec 2024
Q3 2024 4.2% -2.4% -36% 30 Sep 2024
Q2 2024 3.6% -3.3% -47% 30 Jun 2024
Q1 2024 3.7% -4.6% -55% 31 Mar 2024
Q4 2023 6.1% -0.32% -5% 31 Dec 2023
Q3 2023 6.5% -8.2% -56% 30 Sep 2023
Q2 2023 7% -38% -85% 30 Jun 2023
Q1 2023 8.3% -94% -92% 31 Mar 2023
Q4 2022 6.4% -119% -95% 31 Dec 2022
Q3 2022 15% -127% -90% 30 Sep 2022
Q2 2022 45% -115% -72% 30 Jun 2022
Q1 2022 102% +54% +111% 31 Mar 2022
Q4 2021 126% +94% +303% 31 Dec 2021
Q3 2021 141% +109% +332% 30 Sep 2021
Q2 2021 160% +138% +628% 30 Jun 2021
Q1 2021 48% +28% +133% 31 Mar 2021
Q4 2020 31% +11% +58% 31 Dec 2020
Q3 2020 33% +17% +110% 30 Sep 2020
Q2 2020 22% +6.1% +38% 30 Jun 2020
Q1 2020 21% +4.5% +27% 31 Mar 2020
Q4 2019 20% +3% +18% 31 Dec 2019
Q3 2019 16% -1.7% -9.9% 30 Sep 2019
Q2 2019 16% 30 Jun 2019
Q1 2019 16% 31 Mar 2019
Q4 2018 17% 31 Dec 2018
Q3 2018 17% 30 Sep 2018
Q3 2016 57% 30 Sep 2016
Q2 2016 62% 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.